Abstract
T-cell immunoglobulin and mucin domain-3 (Tim-3) has been suggested to be a critical immune checkpoint target for cancer immunotherapy. However, limit......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
